Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11649 | 964 | 27.5 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
1649 | 2 | LIPOPROTEINA//FAMILIAL HYPERCHOLESTEROLEMIA//APOLIPOPROTEINA | 6893 |
11649 | 1 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//LIPOPROTEIN APHERESIS | 964 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LDL APHERESIS | authKW | 3857141 | 19% | 67% | 182 |
2 | LOW DENSITY LIPOPROTEIN APHERESIS | authKW | 1703342 | 7% | 81% | 66 |
3 | LIPOPROTEIN APHERESIS | authKW | 522591 | 3% | 50% | 33 |
4 | LIPID APHERESIS | authKW | 507581 | 3% | 64% | 25 |
5 | RHEOPHERESIS | authKW | 300305 | 2% | 59% | 16 |
6 | DALI | authKW | 285050 | 2% | 50% | 18 |
7 | MEMBRANE DIFFERENTIAL FILTRATION | authKW | 256559 | 1% | 90% | 9 |
8 | FAMILIAL HYPERCHOLESTEROLEMIA | authKW | 243714 | 9% | 9% | 90 |
9 | DIRECT ADSORPTION OF LIPOPROTEINS | authKW | 221719 | 1% | 100% | 7 |
10 | LDL HEMOPERFUSION | authKW | 221719 | 1% | 100% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 5881 | 24% | 0% | 233 |
2 | Engineering, Biomedical | 5849 | 20% | 0% | 191 |
3 | Transplantation | 4087 | 14% | 0% | 133 |
4 | Peripheral Vascular Diseases | 2064 | 14% | 0% | 136 |
5 | Urology & Nephrology | 1352 | 12% | 0% | 111 |
6 | Materials Science, Biomaterials | 945 | 5% | 0% | 52 |
7 | Cardiac & Cardiovascular System | 734 | 12% | 0% | 115 |
8 | Medicine, General & Internal | 519 | 12% | 0% | 117 |
9 | Medicine, Research & Experimental | 27 | 3% | 0% | 31 |
10 | Endocrinology & Metabolism | 16 | 3% | 0% | 28 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PLASM HE IS UNIT | 96994 | 1% | 44% | 7 |
2 | ATHEROSCLEROSIS LIPOPROT HE IS | 63348 | 0% | 100% | 2 |
3 | LIPOPROT HE IS | 63348 | 0% | 100% | 2 |
4 | OPHTHALMOL OTORHINOLARYNGOIATRY | 63348 | 0% | 100% | 2 |
5 | AUTON NEUROENDOCRINOL | 52784 | 1% | 33% | 5 |
6 | NEUROL INTERNAL MED 3 | 47508 | 0% | 50% | 3 |
7 | EXTRACORPOREAL THER EUT TECH UNIT | 46573 | 1% | 29% | 5 |
8 | DOUBLE CHECK SWISS | 42231 | 0% | 67% | 2 |
9 | EXTRACORPOREAL THER EUT TECH UNIT IMMUNOHEMATOL | 42231 | 0% | 67% | 2 |
10 | MED METAB CARE GERONTOL 3 | 42231 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THERAPEUTIC APHERESIS | 170709 | 3% | 19% | 29 |
2 | ATHEROSCLEROSIS SUPPLEMENTS | 148131 | 4% | 13% | 36 |
3 | THERAPEUTIC APHERESIS AND DIALYSIS | 106256 | 6% | 6% | 61 |
4 | JOURNAL OF CLINICAL APHERESIS | 51308 | 4% | 5% | 36 |
5 | ARTIFICIAL ORGANS | 27568 | 6% | 1% | 62 |
6 | PLASMA THERAPY & TRANSFUSION TECHNOLOGY | 27382 | 2% | 6% | 15 |
7 | INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 17304 | 4% | 1% | 43 |
8 | BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS | 15371 | 1% | 4% | 11 |
9 | TRANSFUSION AND APHERESIS SCIENCE | 14860 | 3% | 2% | 26 |
10 | TRANSFUSION SCIENCE | 8195 | 1% | 2% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LDL APHERESIS | 3857141 | 19% | 67% | 182 | Search LDL+APHERESIS | Search LDL+APHERESIS |
2 | LOW DENSITY LIPOPROTEIN APHERESIS | 1703342 | 7% | 81% | 66 | Search LOW+DENSITY+LIPOPROTEIN+APHERESIS | Search LOW+DENSITY+LIPOPROTEIN+APHERESIS |
3 | LIPOPROTEIN APHERESIS | 522591 | 3% | 50% | 33 | Search LIPOPROTEIN+APHERESIS | Search LIPOPROTEIN+APHERESIS |
4 | LIPID APHERESIS | 507581 | 3% | 64% | 25 | Search LIPID+APHERESIS | Search LIPID+APHERESIS |
5 | RHEOPHERESIS | 300305 | 2% | 59% | 16 | Search RHEOPHERESIS | Search RHEOPHERESIS |
6 | DALI | 285050 | 2% | 50% | 18 | Search DALI | Search DALI |
7 | MEMBRANE DIFFERENTIAL FILTRATION | 256559 | 1% | 90% | 9 | Search MEMBRANE+DIFFERENTIAL+FILTRATION | Search MEMBRANE+DIFFERENTIAL+FILTRATION |
8 | FAMILIAL HYPERCHOLESTEROLEMIA | 243714 | 9% | 9% | 90 | Search FAMILIAL+HYPERCHOLESTEROLEMIA | Search FAMILIAL+HYPERCHOLESTEROLEMIA |
9 | DIRECT ADSORPTION OF LIPOPROTEINS | 221719 | 1% | 100% | 7 | Search DIRECT+ADSORPTION+OF+LIPOPROTEINS | Search DIRECT+ADSORPTION+OF+LIPOPROTEINS |
10 | LDL HEMOPERFUSION | 221719 | 1% | 100% | 7 | Search LDL+HEMOPERFUSION | Search LDL+HEMOPERFUSION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | THOMPSON, GR , (2003) LDL APHERESIS.ATHEROSCLEROSIS. VOL. 167. ISSUE 1. P. 1 -13 | 67 | 80% | 106 |
2 | MORIARTY, PM , HEMPHILL, L , (2016) LIPOPROTEIN APHERESIS.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 45. ISSUE 1. P. 39 -+ | 52 | 67% | 2 |
3 | THOMPSON, GR , (2008) RECOMMENDATIONS FOR THE USE OF LDL APHERESIS.ATHEROSCLEROSIS. VOL. 198. ISSUE 2. P. 247-255 | 39 | 85% | 138 |
4 | MORIARTY, PM , HEMPHILL, L , (2015) LIPOPROTEIN APHERESIS.CARDIOLOGY CLINICS. VOL. 33. ISSUE 2. P. 197 -+ | 51 | 66% | 4 |
5 | JULIUS, U , FISCHER, S , SCHATZ, U , HOHENSTEIN, B , BORNSTEIN, SR , (2013) LIPOPROTEIN APHERESIS: AN UPDATE.CLINICAL LIPIDOLOGY. VOL. 8. ISSUE 6. P. 693-705 | 49 | 64% | 11 |
6 | MORIARTY, PM , (2006) LDL-APHERESIS THERAPY: CURRENT THERAPEUTIC PRACTICE AND POTENTIAL FUTURE USE.FUTURE LIPIDOLOGY. VOL. 1. ISSUE 3. P. 299-308 | 48 | 77% | 6 |
7 | MABUCHI, H , HIGASHIKATA, T , KAWASHIRI, M , (2004) CLINICAL APPLICATIONS OF LONG-TERM LDL-APHERESIS ON AND BEYOND REFRACTORY HYPERCHOLESTEROLEMIA.TRANSFUSION AND APHERESIS SCIENCE. VOL. 30. ISSUE 3. P. 233-243 | 47 | 81% | 7 |
8 | DERFLER, K , STEINER, S , SINZINGER, H , (2015) LIPOPROTEIN-APHERESIS: AUSTRIAN CONSENSUS ON INDICATION AND PERFORMANCE OF TREATMENT.WIENER KLINISCHE WOCHENSCHRIFT. VOL. 127. ISSUE 15-16. P. 655 -663 | 41 | 61% | 1 |
9 | BAMBAUER, R , BAMBAUER, C , LEHMANN, B , LATZA, R , SCHIEL, R , (2012) LDL-APHERESIS: TECHNICAL AND CLINICAL ASPECTS.SCIENTIFIC WORLD JOURNAL. VOL. . ISSUE . P. - | 52 | 46% | 14 |
10 | THOMPSEN, J , THOMPSON, PD , (2006) A SYSTEMATIC REVIEW OF LDL APHERESIS IN THE TREATMENT OF CARDIOVASCULAR DISEASE.ATHEROSCLEROSIS. VOL. 189. ISSUE 1. P. 31-38 | 33 | 80% | 41 |
Classes with closest relation at Level 1 |